Vivanza Biosciences Ltd. | Income Statement
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
34,746.40
64,403.00
Cost of Goods Sold (COGS) incl. D&A
-
-
-
34,871.70
56,666.00
Gross Income
-
-
-
125.30
7,737.00
SG&A Expense
509.30
525.40
607.80
2,572.00
1,851.00
EBIT
509.40
525.40
607.80
3,026.10
5,886.00
Unusual Expense
25.00
-
-
215.40
-
Non Operating Income/Expense
-
-
5.00
130.80
11.00
Interest Expense
0.30
0.50
0.60
434.40
3,562.00
Pretax Income
534.70
525.90
603.30
3,114.20
2,335.00
Income Tax
-
-
-
-
281.00
Consolidated Net Income
534.70
525.90
603.30
3,114.20
2,054.00
Net Income
534.70
525.90
603.30
3,114.20
2,054.00
Net Income After Extraordinaries
534.70
525.90
603.30
3,114.20
2,054.00
Net Income Available to Common
534.70
525.90
603.30
3,114.20
2,054.00
EPS (Basic)
2.80
2.80
0.96
0.98
0.51
Basic Shares Outstanding
188.00
188.00
627.20
3,185.40
-
EPS (Diluted)
2.84
2.80
0.96
0.98
-
Diluted Shares Outstanding
188.00
188.00
627.20
3,185.40
-
EBITDA
509.40
525.40
607.80
-
5,886.00
Other Operating Expense
-
-
-
328.80
-
About Vivanza Biosciences
View Profile
